Ultime notizie per Brookfield Renewable (NYSE:BEPC) Azioni

Brookfield Renewable

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 20 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.

Brookfield Renewable Corporation Class A Subordinate Voting Shares

Brookfield Renewable Corp

Earnings

News

BSLK

Bolt Projects Holdings Q3 EPS $0.32

WIIM

UPLD

Upland Software shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

Golden Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEN#NASDAQ">GDEN</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.10 by 80 percent. This is a 200 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $161.23 million which missed the analyst consensus estimate of $162.25 million by 0.63 percent. This is a 37.44 percent decrease over sales of $257.73 million the same period last year.

Earnings Beats

Earnings Misses

GDEN

Golden Entertainment Q3 EPS $0.18 Beats $0.10 Estimate, Sales $161.23M Miss $162.25M Estimate

aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent.

ATYR

aTyr Pharma Q3 2024 GAAP EPS $(0.23) Misses $(0.22) Estimate

Spyre Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRE#NASDAQ">SYRE</a>) reported quarterly losses of $(1.36) per share which missed the analyst consensus estimate of $(0.83) by 63.86 percent. This is a 85.44 percent increase over losses of $(9.34) per share from the same period last year.

SYRE

Spyre Therapeutics Q3 EPS $(1.36) Misses $(0.83) Estimate

Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) raises FY2024 Adj EPS guidance from $0.08-0.12 to $0.12-0.14 vs $0.10 analyst estimate. Narrows FY2024 sales outlook from $835.00 million-845.00 million to $837.00 million-843.00 million vs $841.44 million estimate.

Guidance

MYGN

Myriad Genetics Raises FY2024 Adj EPS Guidance from $0.08-0.12 to $0.12-0.14 vs $0.10 Est; Narrows FY2024 Sales Guidance from $835.00M-845.00M to $837.00M-843.00M vs $841.44M Est

LCUT

Lifetime Brands shares are trading lower after the company reported worse-than-expected Q3 financial results and lowered its FY24 guidance and Q4 EPS guidance.

SLDP

Solid Power Continues To Expect 2024 Revenue Of $16M - $20M, Est $19.783M

HeartBeam (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAT#NASDAQ">BEAT</a>) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent.

BEAT

HeartBeam Q3 2024 GAAP EPS $(0.19) Misses $(0.17) Estimate

US Global Investors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROW#NASDAQ">GROW</a>) reported quarterly earnings of $0.02 per share. This is a 300 percent increase over losses of $(0.01) per share from the same period last year. The company reported $2.16 million in sales this quarter. This is a 31.15 percent decrease over sales of $3.13 million the same period last year.

GROW

US Global Investors Q1 EPS $0.02 Up From $(0.01) YoY, Sales $2.16M Down From $3.13M YoY

Innovex International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVX#NYSE">INVX</a>) reported quarterly earnings of $0.25 per share which met the analyst consensus estimate. This is a 47.92 percent decrease over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $151.82 million which beat the analyst consensus estimate of $135.00 million by 12.46 percent. This is a 9.15 percent increase over sales of $139.09 million the same period last year.

INVX

Innovex International Q3 Adj $0.25, Inline, Sales $151.82M Beat $135.00M Estimate

Eventbrite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) sees Q4 sales of $74.000 million-77.000 million vs $75.47 million estimate.

Eventbrite Sees Q4 Sales $74.000M-77.000M vs $75.47M Est

Tectonic Therapeutic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECX#NASDAQ">TECX</a>) reported quarterly losses of $(1.20) per share which missed the analyst consensus estimate of $(0.84) by 42.86 percent.

TECX

Tectonic Therapeutic Q3 2024 GAAP EPS $(1.20) Misses $(0.84) Estimate

Li-Cycle Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LICY#NYSE">LICY</a>) reported quarterly earnings of $2.15 per share which beat the analyst consensus estimate of $(1.32) by 262.88 percent. This is a 241.45 percent increase over losses of $(1.52) per share from the same period last year. The company reported quarterly sales of $8.40 million which beat the analyst consensus estimate of $6.98 million by 20.34 percent. This is a 78.72 percent increase over sales of $4.70 million the same period last year.

LICY

Li-Cycle Holdings Q3 EPS $2.15 Beats $(1.32) Estimate, Sales $8.40M Beat $6.98M Estimate

Definitive Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.08 by 25 percent. This is a 11.11 percent increase over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $62.70 million which beat the analyst consensus estimate of $61.72 million by 1.58 percent. This is a 4.02 percent decrease over sales of $65.33 million the same period last year.

Definitive Healthcare Q3 Adj $0.10 Beats $0.08 Estimate, Sales $62.70M Beat $61.72M Estimate

MeridianLink (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.08 by 25 percent. The company reported quarterly sales of $80.369 million which beat the analyst consensus estimate of $79.969 million by 0.50 percent. This is a 5.07 percent increase over sales of $76.488 million the same period last year.

MLNK

MeridianLink Q3 2024 Adj. EPS $0.06 Misses $0.08 Estimate, Sales $80.369M Beat $79.969M Estimate

Boundless Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOLD#NASDAQ">BOLD</a>) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.82) by 9.76 percent.

BOLD

Boundless Bio Q3 2024 GAAP EPS $(0.74) Beats $(0.82) Estimate

Sports betting and iGaming company DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) reported third-quarter financial results<a href="https://www.benzinga.com/earnings"> after market close Thursday.</a>
Here are the key highlights.
What Happened: DraftKings reported third-quarter revenue of $1.095 billion, up 39% year-over-year. The revenue total missed a Street consensus estimate of $1.112 billion according to data <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110724&amp;t=be2bearmibe3na1">from Benzinga Pro.</a>
The company said revenue growth came from strong customer engagement, the acquisition of new customers, the launch in new territories, and the impact of the acquisition of Jackpocket, which closed in May.
The company reported a loss of 17 cents per share, which beat a Street consensus estimate of a loss of 42 cents per share.
Monthly unique payers (MUP) were 3.6 million in the third quarter, up 55% year-over-year. Excluding the impact of the Jackpocket acquisition, monthly unique payers would have been up 27% year-over-year.
The average revenue per MUP was $103 in the third quarter, down 10% year over year. The lower revenue per payer was due to the Jackpocket acquisition. Excluding the Jackpocket acquisition, the average revenue per MUP was 8% higher year over year.
"DraftKings delivered strong performance in the third quarter with the return of NFL and college football," DraftKings CEO Jason Robins said.
DraftKings was live for mobile sports betting in 25 states and Washington D.C., representing 49% of the U.S. population in the third quarter. The company is also live with iGaming in five states and live for both sportsbook and iGaming in Ontario, Canada.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41792879/draftkings-q3-earnings-highlights-nfl-in-focus-will-missouri-legalization-factor-in">DraftKings Q3 Earnings Preview: NFL In Focus, Will Missouri Legalization Factor Into Guidance?</a>
What's Next: The company lowered its fiscal year 2024 revenue guidance from a range of $5.05 billion to $5.25 billion to a new range of $4.85 billion to $4.95 billion due to customer-friendly sport outcomes in the fourth quarter, which comes with the NFL season having several weeks of favorable outcomes for bettors.
Analysts expect the company to report revenue of $5.14 billion for the full fiscal year, according to data from Benzinga Pro.
The company also revised its 2024 adjusted EBITDA guidance from a range of $340 million to $420 million to a new range of $240 million to $280 million.
DraftKings introduced fiscal year 2025 revenue guidance for the first time, with a range of $6.2 billion to $6.6 billion expected. The company also said it expects 2025 adjusted EBITDA to be in a range of $900 million to $1.0 billion, reaffirming guidance from August.
"With major sports converging on the calendar, we are well-positioned to build on this momentum as we further enhance our top-ranked sportsbook app with additional live betting features and exciting new NBA markets," Robins said. "Our focus remains on driving sustainable revenue growth and profitability in 2025 and beyond."
The company's 2024 and 2025 guidance includes all existing mobile sports betting and iGaming markets and Jackpocket, but does not include any pending state launches.
Missouri legalized sports betting on Election Day 2024 and DraftKings expects to launch its sportsbook in the state pending approval. The company also expects to launch its sportsbook in Puerto Rico, which is pending approval.
DKNG Price Action: DraftKings stock is down 5% to $37.00 in after-hours trading Thursday, versus a 52-week trading range of $28.69 to $49.57.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41725070/draftkings-offers-10k-in-prizes-for-2024-election-predictions-harris-trump-swing-state-performan">DraftKings Offers $10K In Prizes For 2024 Election Predictions: Harris, Trump Swing State Performance Among Key Questions</a></li>
</ul>
Photo: Shutterstock

Sports Betting

Movers

Trading Ideas

DKNG

DraftKings Q3 Highlights: Revenue Miss, 2024 Guidance Trim, First 2025 Outlook, CEO Reaffirms Focus On 'Sustainable Revenue Growth'

QRHC

Quest Resources shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

Eventbrite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.13) by 69.23 percent. This is a 60 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $77.80 million which beat the analyst consensus estimate of $75.83 million by 2.60 percent. This is a 4.59 percent decrease over sales of $81.54 million the same period last year.

Eventbrite Q3 EPS $(0.04) Beats $(0.13) Estimate, Sales $77.80M Beat $75.83M Estimate

Warning: BEPC is at high risk of performing badly

TD Cowen: Three Stocks That Could Benefit From A Canadian Soft Landing

Billionaire Says Global Conditions 'Are Treacherous And Getting Worse': Our Approach

11-14% Yielding Dividend Growers: 2 To Buy And 1 To Sell

Brookfield Renewable: Excellent Outlook For This High-Yielder

Very Good News For Big Dividend Infrastructure Stocks

Brookfield Renewable Preferreds Offer A Great Yield To Likely Redemption

7 Stocks I'm Buying As Recession Fears Fade And Trump Victory Odds Rise

Buy The Dip In These '$10 Trillion Opportunity' Big Dividends Hand-Over-Fist

Brookfield Renewable (BEPC) has released an update. Brookfield Renewable is proposing a reorganization to maintain its advantageous corporate struc...

Brookfield Renewable Plans Strategic Reorganization Amid Tax Changes

AAPL

AMLP

AMZN

ARTNA

ARTNB

BBCA

BEPC

BIPC

BIZD

BRENF

CWEN

EPDU

FLCA

GBDC

HASI

INGXF

LAND

LANDM

LANDO

LANDP

MSFT

NVDA

PLTR

QCLN

REXR

RNRG

SGOV

TRGP

TSLA

TSMWF

VIRT

Press Releases

Brookfield Renewable to Host Second Quarter 2024 Results Conference Call

Dividends

Brookfield Renewable Announces Reset Dividend Rate on Series 3 Preference Shares

Financing

Brookfield Renewable to Issue C$400 Million of Green Bonds

Brookfield Renewable Announces Results of Conversion  Privilege of Series 3 Preference Shares

Brookfield Renewable Announces Strong Second Quarter Results

Commodities

Insurance

CDPQ acquires 25% of UK's First Hydro Company from Brookfield

Masdar to Acquire Saeta from Brookfield for $1.4 Billion

Brookfield Renewable to Host Third Quarter 2024 Results Conference Call

Brookfield Renewable Announces Reorganization of Brookfield Renewable Corporation

Comments

Brookfield Renewable

Notizie

Ultime notizie per Brookfield Renewable (NYSE:BEPC) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO